Table 2.
NTM site of infection and related species
Infection sites | Number of patients affected for each species/number of total cases |
---|---|
Pulmonary [20, 21, 25, 29, 32, 33, 35, 36, 38, 40, 41, 44, 48, 49, 59, 62, 66–68, 76] |
77/175 (44%) MAC, 18 M. abscessus, 10 M. chelonae, 8 M. haemophilum, 8 M. fortuitum, 6 M. xenopi, 4 M. kansasii, 2 M. fortuitum and M. chelonae, 1 M. massiliense, 1 M. scrofulaceum, 1 MAC and M. gordonae, 1 Unclassified, 17 |
Cutaneous [20, 24, 26, 31, 32, 37, 41–43, 45, 46, 50–52, 55, 58, 61, 63, 71, 76] |
43/175 (24.6%) M. haemophilum, 29 M. chelonae, 4 M. fortuitum, 3 M. kansasii, 2 M. abscessus, 1 M. marinum, 1 M. massiliense, 1 M. szulgai, 1 MAC, 1 |
Disseminated [20, 26, 29, 31, 32, 36, 38, 40, 42, 47, 53, 57, 59, 64, 69, 72–74, 76] |
38/175 (21.7%) M. mucogenicum, 8 M. fortuitum, 5 M. haemophilum, 5 MAC, 4 M. chelonae, 4 M. immunogenum, 4 M. abscessus, 3 M. fortuitum and M. haemophilum, 1 M. genavense, 1 M. gordonae, 1 M. massiliense, 1 MAC and M. haemophilum, 1 |
Others |
15/175 (8.6%) MAC, 4 M. chelonae, 4 M. haemophilum, 2 M. abscessus, 1 M. genavense, 1 M. neoaurum, 1 Unclassified, 2 |
Musculoskeletals |
2/175 (1.1%) M. kansasii, 2 |
M. mycobacterium, MAC Mycobacterium avium complex